METTL3-VISTA axis-based combination immunotherapy for APC truncation colorectal cancer
Objective Although immune checkpoint blockade (ICB) therapy represents a bright spot in antitumor immunotherapy, its clinical benefits in colorectal cancer (CRC) are limited. Therefore, a new target for mediating CRC immunosuppression is urgently needed. Adenomatous polyposis coli (APC) mutations ha...
Saved in:
| Main Authors: | Hui Wang, Yujie Zhang, Ling Wu, Liang Zhao, Hao Chen, Rui Bai, Jianghua Wu, Zetao Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-12-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/12/e009865.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mucosal immunotherapy targeting APC in lung disease
by: Yangqi Liu, et al.
Published: (2025-04-01) -
Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy
by: Kaixin Wu, et al.
Published: (2024-11-01) -
Colorectal tumors from APC*I1307K carriers principally harbor somatic APC mutations outside the A8 tract.
by: Peter Zauber, et al.
Published: (2014-01-01) -
Comparative Analysis of the Immunohistochemical Expression of the Parkin and APC proteins in Polyps and Colorectal Adenocarcinomas
by: William Augusto Casteleins, et al.
Published: (2025-01-01) -
Cryo-EM structures of apo-APC/C and APC/CCDH1:EMI1 complexes provide insights into APC/C regulation
by: Anna Höfler, et al.
Published: (2024-11-01)